Dioscin alleviates hashimoto’s thyroiditis by regulating the SUMOylation of IRF4 to promote CD4⁺CD25⁺Foxp3⁺ treg cell differentiation

References

• Fisher D, Oddie TH, Johnson DE, et al. The diagnosis of hashimoto's thyroiditis. J Clin Endocrinol Metab. 1975;40(5):795–801.
   PubMed Web of Science ®Google Scholar
• Brix TH, Ferløv-Schwensen C, Thvilum M, et al. Death by unnatural causes, mainly suicide, is increased in patients with Hashimoto’s thyroiditis. A nationwide Danish register study. Endocrine. 2019;65(3):616–622.
   PubMed Web of Science ®Google Scholar
• Krysiak R, Kowalcze K, Okopień B. The effect of spironolactone on thyroid autoimmunity in euthyroid men with Hashimoto's thyroiditis. J Clin Pharm Ther. 2019;44(5):742–749.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim Y, Choi J-W, et al. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168(3):343–349.
   PubMed Web of Science ®Google Scholar
• Zirilli G, Salzano G, Corica D, et al. Thyrotropin serum levels and coexistence with Hashimoto’s thyroiditis as predictors of malignancy in children with thyroid nodules. Ital J Pediatr. 2019;45(1):96.
   PubMed Web of Science ®Google Scholar
• Hoyer KK, Kuswanto WF, Gallo E, et al. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood. 2009;113(2):389–395.
   PubMed Web of Science ®Google Scholar
• Yi H, Tieshan W, Xiangyu G, et al. Protective effects of Jiayan Kangtai granules on autoimmune thyroiditis in a rat model by modulating Th17/Treg cell balance. J Traditional Chin Med. 2018;38(3):380–390.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang Y, Ding X, et al. The proportion of peripheral blood Tregs among the CD4 + T cells of autoimmune thyroid disease patients: a meta-analysis. Endocr J. 2020;67(3):317–326.
   PubMed Web of Science ®Google Scholar
• Yang M, Su L, Tao Q, et al. Depletion of regulatory T cells in visceral adipose tissues contributes to insulin resistance in Hashimoto's Thyroiditis. Front Physiol. 2018;9:136.
   PubMed Web of Science ®Google Scholar
• Yang X, Lun Y, Jiang H, et al. SIRT1-regulated abnormal acetylation of FOXP3 induces regulatory T-cell function defect in Hashimoto's thyroiditis. Thyroid. 2018;28(2):246–256.
   PubMed Web of Science ®Google Scholar
• Stana T, Mario t, Ljubica G-O, et al. The expression of T Cell FOXP3 and T-bet is upregulated in severe but not euthyroid Hashimoto’s thyroiditis. Mediators Inflammation. 2016;2016:3687420.
   PubMed Web of Science ®Google Scholar
• Ehlers M, Schott M. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab. 2014;25(12):656–664.
   PubMed Web of Science ®Google Scholar
• Huber M, Lohoff M. IRF4 at the crossroads of effector T-cell fate decision. Eur J Immunol. 2014;44(7):1886–1895.
   PubMed Web of Science ®Google Scholar
• De Silva NS, Simonetti G, Heise N, et al. The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol Rev. 2012;247(1):73–92. May
   PubMedGoogle Scholar
• Man K, Miasari M, Shi W, et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat Immunol. 2013;14(11):1155–1U79.
   PubMed Web of Science ®Google Scholar
• Raczkowski F, Ritter J, Heesch K, et al. The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells. Proc Natl Acad Sci U S A. 2013;110(37):15019–15024.
   PubMed Web of Science ®Google Scholar
• Huber M, Heink S, Pagenstecher A, et al. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis . J Clin Invest. 2013; Jan123(1):247–260.
   PubMed Web of Science ®Google Scholar
• Kim YM. Regulatory T cells in the human immune system. Korean J Otorhinolaryngol-Head Neck Surg. 2010;53(12):737.
   Google Scholar
• Wei Y, Wagner TE, Thorne RF, et al. Regulatory T cells and cancer therapy: an old story with a new hope. CCTR. 2010;6(1):34–40.
   Google Scholar
• Feng Y, Arvey A, Chinen T, et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell. 2014;158(4):749–763.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330–336.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Rasmussen JP, Gavin MA, et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6(11):1142–1151.
   PubMed Web of Science ®Google Scholar
• Williams JW, Tjota MY, Clay BS, et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun. 2013;4:2990
   PubMed Web of Science ®Google Scholar
• Loosdregt J, Coffer PJ. Post-translational modification networks regulating FOXP3 function. Trends Immunol. 2014;35(8):368–378.
   PubMed Web of Science ®Google Scholar
• Dawlaty MM, Malureanu L, Jeganathan KB, et al. Resolution of sister centromeres requires? RanBP2-Mediated SUMOylation of Topoisomerase IIα. 2008;133(1):0–115.
   Google Scholar
• Cretney E, Xin A, Shi W, et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol. 2011;12(4):304–311.
   PubMed Web of Science ®Google Scholar
• Decque A, Joffre O, Magalhaes JG, et al. Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing. Nat Immunol. 2016;17(2):140–149.
   PubMed Web of Science ®Google Scholar
• Flotho A, Melchior F. Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem. 2013;82(1):357–385.
   PubMedGoogle Scholar
• Feng JF, Tang YN, Ji H, et al. Biotransformation of dioscorea nipponica by rat intestinal microflora and cardioprotective effects of diosgenin. Oxid Med Cell Longev. 2017;2017(2):4176518.
   PubMedGoogle Scholar
• Feng-Xia L. Studies on tissue culture for Dioscorea nipponica. J Shenyang Agricultural Univ. 2004;35(1):4–6.
   Google Scholar
• Lee KA, Jin HY, Baek HS, et al. Importance of careful Tc-MIBI interpretation in patients with thyroid cancer and primary hyperparathyroidism. Korean J Intern Med. 2015;30(4):556–557.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yan T, Ma L, et al. Effects of the total saponins from dioscorea nipponica on immunoregulation in aplastic anemia mice. Am J Chin Med. 2015;43(02):289–303.
   PubMedGoogle Scholar
• Cao Y-j, Li J. A Study of the impact of dioscorea nipponica on the level of serum TSH,TGAb and TPO-Ab of Hashimoto's thyroiditis patient. Chinese General Practice. 2013;16(7C):2486–2488.
   Google Scholar
• Cao Y-j, Xu Z-j, Chen Y-q, et al. Effects of dioscorea nipponica on the expression of Th17/Treg cytokines in patients with hashimoto thyroiditis. China J Traditional Chin Med Pharm. 2016;31(8):3294–3297.
   Google Scholar
• Cao Y-j, Luo Y-p, Xu Z-j, et al. Effects of saponins of Chuanshanlong on the expression of Th1/Th2 cytokines in experimental Hashimoto's thyroiditis rats. Jiangsu J Traditional Chin Med. 2016;48(2):81–85.
   Google Scholar
• Liu J-Y, Hou Y-L, Cao R, et al. Protodioscin ameliorates oxidative stress, inflammation and histology outcome in Complete Freund’s adjuvant induced arthritis rats. Apoptosis. 2017;22(11):1454–1460.
   PubMed Web of Science ®Google Scholar
• Yang B, Xu B, Zhao H, et al. Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1/Nrf2 and p38 MAPK pathways. Mol Med Rep. 2018;18(1):973–980.
   PubMed Web of Science ®Google Scholar
• Yang R, Chen W, Lu Y, et al. Dioscin relieves endotoxemia induced acute neuro-inflammation and protect neurogenesis via improving 5-HT metabolism. Sci Rep. 2017;7:40035.
   PubMed Web of Science ®Google Scholar
• Zhang W, Yin L, Tao X, et al. Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation. Environ Toxicol Pharmacol. 2016;45:193–201.
   PubMed Web of Science ®Google Scholar
• Zou X, Zhang XX, Liu XY, et al. Renal kallikrein activation and renoprotection after dual blockade of renin-angiotensin system in diet-induced diabetic nephropathy. J Diabetes Res. 2015;2015:1–10.
   Web of Science ®Google Scholar
• Liu W, Zhao Z, Wang Y, et al. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway. Cell Death Dis. 2018;9(3):343
   PubMedGoogle Scholar
• Ma T, Wang R-p, Zou X. Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR. BMC Complement Altern Med. 2016;16(1):383
   PubMedGoogle Scholar
• Tong Q, Yong Q, Wu Y, et al. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AICT/MAPK signaling pathways. Toxicol Appl Pharmacol. 2014;281(2):166–173.
   PubMed Web of Science ®Google Scholar
• Alleva E, Santucci D. Guide for the care and use of laboratory animals. Ethology. 1997;103(12):1072–1073.
   Web of Science ®Google Scholar
• Song XH, Zan RZ, Yu CH, et al. Effects of modified Haizao Yuhu Decoction in experimental autoimmune thyroiditis rats. J Ethnopharmacol. 2011;135(2):321–324.
   PubMed Web of Science ®Google Scholar
• Cui CP, Wong CC-L, Kai AK-L, et al. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop. Gut. 2017;66(12):2149–2159. gutjnl-2016-313264.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang T, Fang M, et al. Podocytes protect glomerular endothelial cells from hypoxic injury via deSUMOylation of HIF-1α signaling. Int J Biochem Cell Biol. 2014;58:17-27.
   PubMed Web of Science ®Google Scholar
• Yang Y, Fu W, Chen J, et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat Cell Biol. 2007;9(11):1253–1262.
   PubMed Web of Science ®Google Scholar
• Brown PW, Hwang K, Schlegel PN, et al. Small ubiquitin-related modifier (SUMO)-1, SUMO-2/3 and SUMOylation are involved with centromeric heterochromatin of chromosomes 9 and 1 and proteins of the synaptonemal complex during meiosis in men. Hum Reprod. 2008;23(12):2850–2857.
   PubMed Web of Science ®Google Scholar
• Eaton EM, Sealy L. Modification of CCAAT/Enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3 . J Biol Chem. 2003;278(35):33416–33421.
   PubMed Web of Science ®Google Scholar
• Girdwood DWH. Transcriptional regulation mediated through the conjugation and deconjugation of the small ubiquitin-like modifiers SUMO-1, SUMO-2, and SUMO-3. University of St. Andrews. 2004;
   Google Scholar
• Vanarotti M, Evison BJ, Actis ML, et al. Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance. Bioorg Med Chem. 2018;26(9):2345–2353.
   PubMed Web of Science ®Google Scholar
• Yoo W, Cho E-B, Kim S, et al. The E3 ubiquitin ligase MARCH2 regulates ERGIC3-dependent trafficking of secretory proteins. J Biol Chem. 2019;294(28):10900–10912.
   PubMed Web of Science ®Google Scholar